About me
James Lovett is Chief Executive Officer and Board Member of Myonex Inc., a leading clinical trial supply company with operations in US, France, Germany and UK and distribution to 80 countries. Myonex partners with pharma and biotech companies, CROs, and other pharma service providers to provide flexible, comprehensive solutions for their trial supply and commercial packaging needs. Prior to Myonex, James spent 14 years as Corporate Senior Vice President of Covance until its sale to Labcorp. James has served on the boards of directors of the Wistar Institute, National Association for Biomedical Research, FoodChain ID, and Bioclinica. He is a graduate of Northwestern University and Harvard Law School.
LinkedIn
